Abstract
The current American College of Medical Genetics and Genomics (ACMG) guidelines recommend genetic testing for all patients with neurodevelopmental disorders (NDDs) including ASD, intellectual disability, and global developmental delay. Even with strong evidence-based recommendations, there are many patients with NDDs who do not receive a clinical genetics evaluation or diagnostic testing for a variety of reasons, often complicated by a general lack of access to quality medical care for children with NDDs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have